Obesity’s Epigenetic ‘Memory’ Fuels Weight Regain
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Obesity’s Epigenetic ‘Memory’ Fuels Weight Regain" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include AOL.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 36d ago.
Quick answers
Why is "Obesity’s Epigenetic ‘Memory’ Fuels Weight Regain" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
Topics
Related trends
Validation of clinical and preclinical obesity across global cohorts
A new diagnostic framework for obesity outperforms BMI by distinguishing clinical obesity from pre-clinical states.
Google rolls out Gemini Memory summary to let you see and edit what it remembers about you
Google is rolling out a Memory summary for Gemini that lets eligible users see, correct, and delete what the assistant remembers.
6-minute daily habit could help Ozempic users preserve muscle, expert says
A 40-week study found that resistance training helped people taking tirzepatide lose 25% less lean tissue while improving strength by 10%.
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
Less Than 42 Minutes of Bright Light Daily Is a Stronger Predictor of Dementia Than Obesity, Study Finds
A study of 87,577 UK adults found that getting less than 42 minutes of bright daytime light daily predicts dementia risk more strongly than obesity, alcohol use, hearing loss, air pollution, traumatic brain injury, or vitamin D supplement use.
Obesity drugs may help protect memory and cognitive abilities - News-Medical
A major review of nearly 200 preclinical studies and major clinical trials finds that GLP-1 obesity drugs may protect the brain, but randomized trials have not shown a clear cognitive benefit.